Toggle menu

SALI Study

Start date:
August 2016
End date:
December 2019
Co-ordinated by:
Julia Grahamslaw
Main trial site:
Royal Infirmary of Edinburgh

Aim

This is a study looking at incidence and risk factors for poor ankle functional recovery, and the development and progression of post-traumatic ankle osteoarthritis after significant ankle ligament injury.

Trial Design

Longitudinal prospective cohort questionnaire study

Eligibility criteria

Patients of 18 yrs and older, with isolated ankle injuries, who meet the Ottawa Ankle Rules positive (OAR+) criteria (Buffalo modification), but are negative for a significant ankle fracture on subsequent x-ray, will be included in the study.

Local PI

Professor Alasdair Gray

Honorary Professor of Emergency Medicine & Clinical Director of the Emergency Department

Research Team

Julia Grahamslaw

Lead Research Nurse

Caroline Blackstock

AMU Senior Research Nurse

Dr Adam Lloyd

Honorary Research Fellow & Lecturer

Alison Williams

Senior Research Nurse

Claire Cheyne

Senior Research Nurse

More EMERGE Trials

Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users.

Read more

IONA Study

Identification of Novel Psychoactive Substances (IONA)

To determine the association between high-sensitivity cardiac troponin concentration and obstructive coronary artery disease in patients presenting to the Emergency Department with suspected acute coronary syndrome and cardiac troponin concentration within the normal reference range using CTCA.

Read more

PRECISE-CTCA Trial

To determine the association between high-sensitivity cardiac troponin concentration and obstructive coronary artery disease in patients presenting to the Emergency Department with suspected acute coronary syndrome and cardiac troponin concentration within the normal reference range using CTCA.

ISARIC4C – Coronavirus Clinical Characterisation Consortium, an observational study

ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK)